CHINAAMC Hang Seng Biotech ETF (HKG:9069)
Hong Kong · Delayed Price · Currency is HKD · Price in USD 2.038
+0.072 (3.66%)
Last updated: Apr 15, 2026, 9:33 AM HKT
47.68% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | 0.05 |
| Dividend Yield | 0.33% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 56.02% |
| 1-Year Return | +48.18% |
| Volume | 13,500 |
| Open | 2.038 |
| Previous Close | 1.966 |
| Day's Range | 2.038 - 2.038 |
| 52-Week Low | 1.322 |
| 52-Week High | 2.366 |
| Beta | n/a |
| Holdings | 10 |
| Inception Date | n/a |
About 9069
CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.
Asset Class Equity
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9069
Performance
9069 had a total return of 48.18% in the past year, including dividends. Since the fund's inception, the average annual return has been -10.54%.
Top Holdings
67.71% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc. | 2269 | 10.46% |
| BeOne Medicines AG | 6160 | 9.35% |
| Innovent Biologics, Inc. | 1801 | 8.48% |
| Akeso, Inc. | 9926 | 8.07% |
| CSPC Pharmaceutical Group Limited | 1093 | 6.59% |
| Sino Biopharmaceutical Limited | 1177 | 6.18% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 5.30% |
| 3SBio Inc. | 1530 | 4.56% |
| WuXi AppTec Co., Ltd. | 2359 | 4.48% |
| Citigroup Global Markets Holdings Inc. | C.0 02.18.27 000A | 4.24% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | 0.050 HKD | Dec 31, 2025 |
| Dec 18, 2024 | 0.060 HKD | Dec 31, 2024 |
| Dec 18, 2023 | 0.02997 HKD | Dec 29, 2023 |
| Dec 19, 2022 | 0.03997 HKD | Dec 30, 2022 |